Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

Underlying Mechanism Identified for Prostate Cancer Caused by Cadmium

By BiotechDaily International staff writers
Posted on 18 Apr 2012
The widespread, extremely toxic heavy metal cadmium, classified as a Group 1 human carcinogen by the International Agency for Research on Cancer and the US National Toxicology Program, has now been shown to induce apoptosis resistance related to carcinogenesis in human prostrate cells.

An established lung carcinogen in humans, cadmium has also been suspected of playing a role in the induction and the development of prostate cancer, one of the most commonly diagnosed cancers in men. Though multiple molecular targets have been identified, which suggests that more than a single pathway may be involved, specific molecular events of the underlying mechanism(s) have remained elusive. It has been hypothesized that a key factor in cadmium-induced malignant transformation is acquisition of apoptotic resistance. In the present study, published online March 20, 2012, in the journal PLoS ONE, scientists investigated cultured cells derived from human prostate epithelium for effects of cadmium exposure on apoptosis and on the expression of some tumor suppressor proteins.

Initially, the normal RWPE-1 cell line was tested and compared with the response of its cadmium-transformed derivative CTPE. Subsequently, different prostate cancer cell lines were analyzed, including primary adenocarcinoma (22Rv1 and CWR-R1) and metastatic adenocarcinoma cells (LNCaP, PC-3, and DU145). Cells were treated for 24 hours with different concentrations of CdCl(2) , upon which apoptosis, cell cycle distribution, and expression of tumor suppressor proteins were analyzed. Concentrations relevant to human exposure were used: cadmium concentrations (10-30 µM) that are within the range that have been found in normal, hypertrophic, and malignant human prostate tissues and that, at the same time, are able to trigger apoptosis in cell culture systems.

Cellular response to cadmium was also evaluated after siRNA-mediated p53 silencing in wild type p53-expressing RWPE-1 and LNCaP cells, and after adenoviral p53 overexpression in p53-deficient DU145 and PC-3 cell lines. These and additional data showed that p53 silencing was able to suppress cadmium-induced apoptosis. The results demonstrated that cadmium can induce p53-dependent apoptosis in human prostate epithelial cells and suggest p53 mutation as a possible contributing factor for the acquisition of apoptotic resistance in cadmium prostatic carcinogenesis.

“In our study, we investigated the effects of cadmium exposure in normal and in tumor cells derived from human prostate tissue,” said Dr. Pier Paolo Claudio, lead scientist of the study and associate professor in the Biomedical Sciences Graduate Program and Department of Biochemistry and Microbiology in the Joan C. Edwards School of Medicine at Marshall University (Huntington, WV, USA). “The focus of work in our laboratory is to understand the molecular mechanisms governing malignant transformation in order to tailor novel therapeutic strategies. To effectively design novel biological drugs, a thorough understanding of the mechanism of cancer pathogenesis is required,” he added.

The authors, part of a collaborative effort between multiple institutions in Italy and the USA, noted that since the acquisition of apoptotic resistance appears to be crucial in cadmium-induced malignant transformation, further characterization of the pathways involved as well as a thorough comparative proteome analysis of the different prostate epithelial cells studied would significantly improve understanding of cadmium carcinogenesis in the prostate.

Related Links:

Marshall University




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.